NYT: A Cancer Drug Shows Promise, at a Price That Many Can’t Pay: “Genentech plans to charge about $100,000 a year for the drug Avastin as a treatment for breast and lung cancer.”

It certainly shows evidence of a well thought-out marketing program when you name your only-for-the-wealthy drug after a pre-boarding pirate cry.